Connect with us

Coronavirus Outbreak

COVID-19 ICU Patients At Risk Of Acute Brain Dysfunction, Says Study

Nearly 82 per cent of the COVID-19 patients in the study were in coma stage for an average of 10 days, and 55 per cent were delirious for an average of three days

COVID-19 ICU Patients At Risk Of Acute Brain Dysfunction, Says Study
Highlights
  • Experts noted that acute brain dysfunction lasted for an average of 12 days
  • ICU delirium is associated with higher risk of death: Scientists
  • 2,000 COVID-19 patients were observed for conducting the study

New Delhi: COVID-19 patients admitted to intensive care in the early months of the pandemic experienced a higher burden of delirium and coma than is typically found in those hospitalised with acute respiratory failure, according to the largest study of its kind to date. The research, published in The Lancet Respiratory Medicine journal, tracked the incidence of delirium and coma in over 2,000 COVID-19 patients admitted before April 28, 2020, to 69 adult intensive care units across 14 countries.

Also Read: As India Gears Up To Kick-starts COVID-19 Vaccination Drive From January 16, Expert Explains When Will The Common Man Get The Vaccine

According to the scientists, led by those at Vanderbilt University Medical Center in the US, the choice of sedative medications and curbs on family visitation played a role in increasing acute brain dysfunction for these patients. They said ICU delirium is associated with higher medical costs and greater risk of death and long-term ICU-related dementia.

Nearly 82 per cent of the patients in the study were comatose for a median of 10 days, and 55 per cent were delirious for a median of three days. The scientists noted that acute brain dysfunction lasted for an average of 12 days. “This is double what is seen in non-COVID ICU patients,” said study co-author Brenda Pun from VUMC.

The scientists believe COVID-19 could predispose patients to a higher burden of acute brain dysfunction. However, they also noted that patient care factors, some of which are related to pressures posed on health care by the pandemic, also appear to have played a significant role.

Also Read: COVID-19 Vaccination To Start In India On Jan 16; 3 Crore Healthcare, Frontline Workers To Get Shots First

With respect to COVID-19, the scientists believe there has been widespread abandonment of newer clinical protocols that are proven to help ward off the acute brain dysfunction that usually affects many critically ill patients.

It is clear in our findings that many ICUs reverted to sedation practices that are not in line with best practice guidelines and we’re left to speculate on the causes. Early reports of COVID-19 suggested that the lung dysfunction seen required unique management techniques including deep sedation. In the process, key preventive measures against acute brain dysfunction went somewhat by the boards, Ms. Pun said.

Analysing patient characteristics from electronic health records, and care practices and findings from clinical assessments, the scientists found that about 90 per cent of patients tracked in the study were invasively mechanical ventilated at some point during hospitalisation, and 67 per cent on the day of ICU admission. Patients receiving benzodiazepine sedative infusions were at 59 per cent higher risk of developing delirium, they added. In comparison, the patients who received family visitation were at 30 per cent lower risk of delirium, the study noted.

There’s no reason to think that, since the close of our study, the situation for these patients has changed. These prolonged periods of acute brain dysfunction are largely avoidable. ICU teams need above all to return to lighter levels of sedation for these patients, frequent awakening and breathing trials, mobilisation and safe in-person or virtual visitation, said study senior author, Pratik Pandharipande.

Also Read: Amid Short Supplies, Vaccine Doses Can Be Six Weeks Apart, Says WHO

(Except for the headline, this story has not been edited by NDTV staff and is published from a syndicated feed.)

NDTV – Dettol Banega Swasth India campaign is an extension of the five-year-old Banega Swachh India initiative helmed by Campaign Ambassador Amitabh Bachchan. It aims to spread awareness about critical health issues facing the country. In wake of the current COVID-19 pandemic, the need for WASH (WaterSanitation and Hygiene) is reaffirmed as handwashing is one of the ways to prevent Coronavirus infection and other diseases. The campaign highlights the importance of nutrition and healthcare for women and children to prevent maternal and child mortality, fight malnutrition, stunting, wasting, anaemia and disease prevention through vaccines. Importance of programmes like Public Distribution System (PDS), Mid-day Meal Scheme, POSHAN Abhiyan and the role of Aganwadis and ASHA workers are also covered. Only a Swachh or clean India where toilets are used and open defecation free (ODF) status achieved as part of the Swachh Bharat Abhiyan launched by Prime Minister Narendra Modi in 2014, can eradicate diseases like diahorrea and become a Swasth or healthy India. The campaign will continue to cover issues like air pollutionwaste managementplastic banmanual scavenging and sanitation workers and menstrual hygiene

Folk Music For A Swasth India

RajasthanDay” src=

Reckitt’s Commitment To A Better Future

Expert Blog

हिंदी में पड़े

Latest Posts